As of April 16, 2025, Laboratorios Farmaceuticos Rovi (ROVI.MC) has a market cap of $2.89 billion USD. According to our data, Laboratorios Farmaceuticos Rovi is ranked No.3407 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $2.89 B |
-20.68%
|
Dec 31, 2024 | $3.64 B |
5.94%
|
Dec 29, 2023 | $3.44 B |
72.21%
|
Dec 30, 2022 | $2.00 B |
-50.33%
|
Dec 30, 2021 | $4.02 B |
95.99%
|
Dec 31, 2020 | $2.05 B |
56.02%
|
Dec 31, 2019 | $1.31 B |
40.39%
|
Dec 31, 2018 | $0.94 B |
12.38%
|
Dec 29, 2017 | $0.83 B |
28.30%
|
Dec 30, 2016 | $0.65 B |
-13.72%
|
Dec 31, 2015 | $0.75 B |
41.88%
|
Dec 31, 2014 | $0.53 B |
5.01%
|
Dec 31, 2013 | $0.50 B |
92.05%
|
Dec 31, 2012 | $0.26 B |
6.74%
|
Dec 30, 2011 | $0.25 B |
9.35%
|
Dec 30, 2010 | $0.23 B |
-36.07%
|
Dec 30, 2009 | $0.35 B |
34.25%
|
Dec 30, 2008 | $0.26 B |
-45.18%
|
Dec 28, 2007 | $0.48 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
![]() Novo Nordisk A/S
NOVO-B.CO
|
$285.97 B |
64.050 B
|
![]() Denmark
|
![]() Roche
ROG.SW
|
$249.63 B |
38.060 B
|
![]() Switzerland
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() CVS Health
CVS
|
$87.00 B |
-0.003 M
|
![]() USA
|
![]() Chugai Pharmaceutical
4519.T
|
$77.18 B |
0.794 B
|
![]() Japan
|
![]() CSL
CSL.AX
|
$74.79 B |
-0.212 B
|
![]() Australia
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
Market Cap | = | ROVI.MC Stock Price | * | ROVI.MC Shares Outstanding |
= | $56.45 | * | 51.15 M | |
= | $2.89 B |